Myomo, Inc. Cost of Revenue
Myomo, Inc. (MYO) reported Cost of Revenue of $72.90 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-05
- Myomo, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $72.90K, a 21.10% increase year-over-year.
- Myomo, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $59.60K, a 83.95% increase year-over-year.
- Myomo, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $1.80K.
- Myomo, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $97.50K, a 26.47% decline year-over-year.
- Myomo, Inc. cost of goods and services sold for fiscal 2025 was $109.00K, a 15.57% decline from fiscal 2024.
- Myomo, Inc. cost of goods and services sold for fiscal 2024 was $129.10K, a 98.01% increase from fiscal 2023.
- Myomo, Inc. cost of goods and services sold for fiscal 2023 was $65.20K.
- Myomo, Inc. cost of goods and services sold for fiscal 2021 was $112.90K, a 75.31% decline from fiscal 2020.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72.90K 10-Q · filed 2026-08-05 | $95.40K 10-Q · filed 2026-08-05 | $134.30K derived: sum of 3 quarters · filed 2026-08-05 | $231.80K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $59.60K 10-Q · filed 2026-05-07 | $61.40K derived: sum of 2 quarters · filed 2026-05-07 | $158.90K derived: sum of 3 quarters · filed 2026-05-07 | $219.10K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $1.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $99.30K derived: sum of 2 quarters · filed 2026-03-09 | $159.50K derived: sum of 3 quarters · filed 2026-08-05 | $109.00K 10-K · filed 2026-03-09 | ||
| 2025-09-30 | $97.50K 10-Q · filed 2025-11-10 | $157.70K derived: sum of 2 quarters · filed 2026-08-05 | $107.20K 10-Q · filed 2025-11-10 | $178.40K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $60.20K 10-Q · filed 2026-08-05 | $92.60K 10-Q · filed 2026-08-05 | $80.90K derived: sum of 3 quarters · filed 2026-08-05 | $213.50K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $32.40K 10-Q · filed 2026-05-07 | $20.70K derived: sum of 2 quarters · filed 2026-05-07 | $153.30K derived: sum of 3 quarters · filed 2026-05-07 | $275.10K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$11.70K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $120.90K derived: sum of 2 quarters · filed 2026-03-09 | $242.70K derived: sum of 3 quarters · filed 2026-03-09 | $129.10K 10-K · filed 2026-03-09 | $216.40K 10-K · filed 2025-03-10 | |
| 2024-09-30 | $132.60K 10-Q · filed 2025-11-10 | $107.20K 10-Q · filed 2024-11-06 | $254.40K derived: sum of 2 quarters · filed 2025-11-10 | $140.80K 10-Q · filed 2025-11-10 | $354.80K derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | $121.80K 10-Q · filed 2025-08-11 | $144.60K 10-Q · filed 2025-08-11 | $222.20K derived: sum of 3 quarters · filed 2025-08-11 | $255.00K derived: sum of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | $112.10K 10-Q · filed 2025-05-07 | $100.40K derived: sum of 2 quarters · filed 2025-05-07 | $133.20K derived: sum of 3 quarters · filed 2025-05-07 | $398.80K derived: sum of 4 quarters · filed 2025-05-07 | ||
| 2023-12-31 | -$11.70K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $21.10K derived: sum of 2 quarters · filed 2025-03-10 | $286.70K derived: sum of 3 quarters · filed 2025-03-10 | $65.20K 10-K · filed 2025-03-10 | ||
| 2023-09-30 | $32.80K 10-Q · filed 2024-11-06 | $298.40K derived: sum of 2 quarters · filed 2024-11-06 | $76.90K 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | $265.60K 10-Q · filed 2024-08-06 | $366.80K 10-Q · filed 2024-08-06 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-13 | $0.00 derived: sum of 3 quarters · filed 2023-03-13 | $112.90K 10-K · filed 2023-03-13 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $112.90K 10-Q · filed 2022-11-10 | $214.90K derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $112.90K 10-Q · filed 2022-08-03 | $214.90K derived: sum of 3 quarters · filed 2022-08-03 | $298.50K derived: sum of 4 quarters · filed 2022-08-03 | ||
| 2021-03-31 | $112.90K 10-Q · filed 2022-05-11 | $214.90K derived: sum of 2 quarters · filed 2022-05-11 | $298.50K derived: sum of 3 quarters · filed 2022-05-11 | $383.10K derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2020-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $185.60K derived: sum of 2 quarters · filed 2022-03-11 | $270.20K derived: sum of 3 quarters · filed 2022-03-11 | $457.20K 10-K · filed 2022-03-11 | ||
| 2020-09-30 | $83.60K 10-Q · filed 2021-11-10 | $168.20K derived: sum of 2 quarters · filed 2021-11-10 | $355.20K 10-Q · filed 2021-11-10 | $424.00K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $84.60K 10-Q · filed 2021-08-09 | $188.10K 10-Q · filed 2021-08-09 | $340.40K derived: sum of 3 quarters · filed 2021-08-09 | $435.40K derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $103.50K 10-Q · filed 2021-05-05 | $255.80K derived: sum of 2 quarters · filed 2021-05-05 | $350.80K derived: sum of 3 quarters · filed 2021-05-05 | $475.80K derived: sum of 4 quarters · filed 2021-05-05 | ||
| 2019-12-31 | $152.30K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $247.30K derived: sum of 2 quarters · filed 2021-03-10 | $372.30K derived: sum of 3 quarters · filed 2021-03-10 | $490.50K 10-K · filed 2021-03-10 | ||
| 2019-09-30 | $95.00K 10-Q · filed 2020-11-10 | $220.00K derived: sum of 2 quarters · filed 2020-11-10 | $338.20K 10-Q · filed 2020-11-10 | $463.00K derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $125.00K 10-Q · filed 2020-08-10 | $235.00K 10-Q · filed 2020-08-10 | $368.00K derived: sum of 3 quarters · filed 2020-08-10 | $533.30K derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2019-03-31 | $110.00K 10-Q · filed 2020-05-14 | $243.00K derived: sum of 2 quarters · filed 2020-05-14 | $408.30K derived: sum of 3 quarters · filed 2020-05-14 | $513.30K derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $298.30K derived: sum of 2 quarters · filed 2020-03-13 | $403.30K derived: sum of 3 quarters · filed 2020-03-13 | $530.30K 10-K · filed 2020-03-13 | ||
| 2018-09-30 | $165.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $270.30K derived: sum of 2 quarters · filed 2019-11-12 | $397.30K 10-Q · filed 2019-11-12 | $539.70K derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $232.00K 10-Q · filed 2019-08-08 | $374.40K derived: sum of 3 quarters · filed 2019-08-08 | |||
| 2018-03-31 | $127.00K 10-Q · filed 2019-05-14 | $269.40K derived: sum of 2 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $142.40K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $356.40K 10-K · filed 2019-03-12 | ||||
| 2017-09-30 | $214.00K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B |